Marathon Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.2M Sell
12,217
-75
-0.6% -$19.2K 1.08% 32
2026
Q2
$3.09M Buy
12,292
+110
+0.9% +$23.7K 1.06% 33
2026
Q1
$2.65M Buy
12,182
+318
+3% +$70.5K 1.09% 33
2025
Q4
$2.71M Buy
+11,864
New +$2.7M 1.08% 33

Other funds holding ABBV

Marathon Wealth Advisors's ABBV Position: Q3 2026 in Review

Marathon Wealth Advisors reduced its AbbVie (ABBV) stake by 0.61% in Q3 2026, selling an estimated $19.2K and leaving 12,217 shares worth $3.2M. The position accounts for 1.08% of the portfolio, ranked #32.

Marathon Wealth Advisors first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Marathon Wealth Advisors held 12,217 shares of AbbVie worth $3.2M as of Q3 2026.
  • Marathon Wealth Advisors sold 75 AbbVie shares in Q3 2026, an estimated $19.2K.
  • AbbVie made up 1.08% of Marathon Wealth Advisors's portfolio in Q3 2026, its #32 holding.
  • Marathon Wealth Advisors first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Marathon Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.